The most common side effects of Wegovy are nausea, vomiting, diarrhea, constipation, stomach pain, and stomach upset
National and international guidelines consistently position lifestyle modification as the first-line intervention for obesity treatment
KESIMPTA is also being studied in Phase III clinical trials, including a pediatric MS trial with a planned regulatory submission in 2027, as well as a separate study on a new dosing regimen expected to be filed in 2028 or beyond
Moreover, CR influences insulin signaling pathways, enhances DNA repair mechanisms, and inhibits the mTOR pathway, collectively leading to a decrease in A plaque accumulation and a reduction in tau phosphorylation
If financial commitment is a major barrier for you when accessing weight loss treatment, our team can support you in exploring savings programs and manufacturer discounts